WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoPremedication
Abrir esta carpeta y ver su contenidoGeneral anaesthetics and oxygen
Abrir esta carpeta y ver su contenidoLocal anaesthetics
Abrir esta carpeta y ver su contenidoNon-opioid analgesics
Abrir esta carpeta y ver su contenidoOpioid analgesics and antagonists
Abrir esta carpeta y ver su contenidoMuscle relaxants and cholinesterase inhibitors
Abrir esta carpeta y ver su contenidoBlood substitutes
Cerrar esta carpetaSolutions for correcting water and electrolyte imbalance
Ver el documentoCompound solution of sodium lactate
Ver el documentoGlucose
Ver el documentoGlucose with sodium chloride
Ver el documentoSodium chloride
Ver el documentoPotassium chloride
Abrir esta carpeta y ver su contenidoAntacid for use in obstetric practice
Ver el documentoAnaesthesia at the District Hospital
Ver el documentoSelected WHO publications of related interest
Ver el documentoBack cover


Group: intravenous infusion fluid
Injectable isotonic solution: 50 mg/ml (5%)

Clinical information


• Postoperative fluid replacement in patients with no sodium deficit, until adequate fluid can be taken by mouth.

• Intravenous rehydration of patients suffering from water depletion for whom oral rehydration salts are not suitable.

Dosage and administration

Individual requirements should always be determined on the basis of clinical and, whenever possible, electrolyte monitoring.


Patients must be monitored for signs of intravascular overload. In this event infusion must be slowed or suspended and, if necessary, a rapidly acting diuretic administered (for example furosemide 40 mg i.v.).

Patients with overt or known diabetes additionally require insulin and close biochemical monitoring.

Prolonged parenteral infusion of glucose solutions may inhibit secretion of insulin. To minimize the risk of hyperglycaemia it may be necessary to add insulin to the infusion.

Adverse effects

Infusion of large volumes of glucose solution may cause hyponatraemia.

Unduly rapid replacement may lead to pulmonary oedema.


Glucose solution should be kept in sealed containers.

Ir a la sección anterior
Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018